Adjuvant non-bacteriolytic and anti-inflammatory combination therapy in pneumococcal meningitis: an investigation in a mouse model.

Author: AngeleB, HögenT, HöhneC, KleinM, KoedelU, PfisterH W, TüfekciH

Paper Details 
Original Abstract of the Article :
Therapy with antibiotics, dexamethasone, and supportive intensive care has improved the prognosis of pneumococcal meningitis, but mortality remains high. Here, we investigated an adjunctive combination therapy of the non-bacteriolytic antibiotic daptomycin plus several anti-inflammatory agents to id...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.cmi.2018.03.039

データ提供:米国国立医学図書館(NLM)

Combating Pneumococcal Meningitis: A Multi-pronged Desert Warfare

Pneumococcal meningitis is a serious infection that can lead to devastating complications. This study is like a strategic battle plan in a desert war, exploring different combinations of therapies to combat this formidable foe. Researchers are examining the potential of combining non-bacteriolytic antibiotics with anti-inflammatory agents to improve outcomes for patients with pneumococcal meningitis.

A New Strategy for Meningitis Treatment

The study found that [combining daptomycin, a non-bacteriolytic antibiotic, with several anti-inflammatory agents showed promise as an adjunctive therapy for pneumococcal meningitis]. This finding is like discovering a powerful new weapon in the arsenal of desert warriors, providing a new and potentially more effective way to fight this dangerous infection.

Hope for Meningitis Patients

This research offers hope for patients battling pneumococcal meningitis. The findings suggest that [a combination therapy approach may offer a more effective and less toxic treatment option], potentially leading to better outcomes and a faster recovery for patients.

Dr. Camel's Conclusion

This study is like a wise general strategizing a desert campaign, exploring innovative combinations of therapies to combat pneumococcal meningitis. The findings offer a potential breakthrough in the treatment of this serious infection, bringing hope for improved outcomes and a brighter future for those affected.

Date :
  1. Date Completed 2019-04-25
  2. Date Revised 2019-04-25
Further Info :

Pubmed ID

29649601

DOI: Digital Object Identifier

10.1016/j.cmi.2018.03.039

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.